We are live on ! Find out more
IDYA icon

IDEAYA Biosciences
IDYA

64 hedge funds and large institutions have $262M invested in IDEAYA Biosciences in 2020 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 17 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

900% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 4

483% more capital invested

Capital invested by funds: $45M → $262M (+$217M)

467% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 3

129% more funds holding

Funds holding: 28 → 64 (+36)

14.53% more ownership

Funds ownership: 53.7% → 68.24% (+15%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
64
Holders Change
+36
Holders Change %
+128.57%
% of All Funds
1.31%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
40
Increased
17
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$15.3M
2
BC
Boxer Capital
California
+$11.3M
3
APM
Avidity Partners Management
Texas
+$10.5M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$6.39M
5
BlackRock
BlackRock
New York
+$5.44M

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$4.7M
2
DCM
Driehaus Capital Management
Illinois
-$536K
3
BBA
Baker Bros. Advisors
New York
-$522K
4
BCM
Bridgeway Capital Management
Texas
-$197K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$79K
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
51
JP Morgan Chase
New York
$57K +$31.9K +4,045 New
UBS Group
52
UBS Group
Switzerland
$54K +$24.5K +3,113 +443%
PAM
53
Panagora Asset Management
Massachusetts
$50K +$26.5K +3,362 +2,101%
SO
54
STRS Ohio
Ohio
$44K +$24.4K +3,100 New
Citigroup
55
Citigroup
New York
$23K +$4.58K +582 +56%
Legal & General Group
56
Legal & General Group
United Kingdom
$23K +$12.7K +1,614 New
AA
57
AlphaCentric Advisors
Puerto Rico
$21K +$11.8K +1,500 New
AIP
58
Ameritas Investment Partners
Nebraska
$15K +$8.37K +1,062 New
Osaic Holdings
59
Osaic Holdings
Arizona
$14K +$1.18K +150 +18%
Bank of Montreal
60
Bank of Montreal
Ontario, Canada
$13K +$7.55K +958 New
TRCT
61
Tower Research Capital (TRC)
New York
$9K +$4.74K +601 New
BNP Paribas Financial Markets
62
BNP Paribas Financial Markets
France
$6.41K +$3.55K +451 New
WEC
63
Winslow Evans & Crocker
Massachusetts
$6K – – –
PHK
64
Point72 Hong Kong
Hong Kong
$2K -$260 -33 -17%
PA
65
Perceptive Advisors
New York
– -$4.7M -1,141,484 Closed
BBA
66
Baker Bros. Advisors
New York
– -$522K -126,611 Closed
Susquehanna International Group
67
Susquehanna International Group
Pennsylvania
– -$79K -19,240 Closed
Victory Capital Management
68
Victory Capital Management
Texas
– -$16K -3,916 Closed
1 2
3

IDYA Hedge Fund Activity: Q2 2020 in Review

64 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in IDEAYA Biosciences (IDYA) for Q2 2020, worth a combined $262M — up 483% from $45M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new IDYA positions and 4 closed out — a net gain of 36 holders — while 17 added to existing stakes and 3 trimmed.

The largest buyer was BVF Inc, adding an estimated $15.3M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $4.7M sold.

  • 64 institutional investors held IDEAYA Biosciences (IDYA) as of Q2 2020, up from 28 in Q1 2020.
  • Funds reported $262M of IDEAYA Biosciences stock for Q2 2020, up 483% quarter-over-quarter.
  • 40 funds opened new IDEAYA Biosciences positions in Q2 2020 and 4 closed out, a net change of +36 holders.
  • The largest IDEAYA Biosciences buyer in Q2 2020 was BVF Inc, an estimated $15.3M added.
  • The largest IDEAYA Biosciences seller in Q2 2020 was Perceptive Advisors, an estimated $4.7M sold.

Based on aggregated 13F filings for Q2 2020.